Chrystalina is an Associate Professor in the Nuffield Department of Clinical Neurosciences at the University of Oxford. She is also one of the Official Fellows of the newly founded colleges, Reuben College. Upon finishing her training and PhD at the University of Cambridge, she moved to Oxford to take up a position in Clinical Neurology. There she established her own research group, the NeuroMetrolgy Lab.

Chrystalina's research interest lies primarily in Parkinson's disease. By adopting a variety of quantitative experimental techniques, her team can measure subtle abnormalities of the speed and coordination in various movements such as saccades and motor control.

Her interest in the neurobiological relationship between visual perception and art had led to the development of the Art and Neuroscience Project for the Medical Sciences Division. Many national and international awards awarded Chrystalina's passion and advocacy for public engagement. In 2019 and 2020, she was awarded the Public Engagement with Research Seed fund grant for the project 'Picturing Parkinson's', which aims to bridge the gap between objective research into Parkinson's disease and subjective patient experience of the condition.

Junseok is a medical graduate of Kyungpook National University, Korea (2001) and board certified in Neurosurgery in 2006. He specialised in endoscopic spine, minimally invasive spine and spinal deformity surgery. He has been given the title of “Best Surgeon” in two consecutive years 2018 and 2019 in Wooridual Spine Hospital in Seoul. He won the “Best Paper Award” in the Society for Minimally Invasive Spine Surgery Annual Forum 2016 in La Vegas. Junseok is current the Director of Wooridual Spine Hospital and Adjunct Professor of Ulsan University Medical School.

Danny is a medical graduate at The Chinese University of Hong Kong (CUHK). He completed his specialist training in Neurosurgery in 2004 and was awarded the Douglas Miller Gold Medal for distinction in Neurosurgery by The College of Surgeons of Hong Kong and The Royal College of Surgeons, Edinburgh. He received his overseas training for Neuro-Oncology in MD Anderson Cancer Centre under the mentorship of Professor Alfred Wai-Kwan Yung in 2007.

Danny is currently Honorary Clinical Associate Professor and the Head of the Division of Neurosurgery at Department of Surgery, Prince of Wales Hospital (PWH) / CUHK, and Associate Director of the CUHK Otto Wong Brain Tumour Centre. His special interests include Neuro-Oncology, glioma surgery and functional Neurosurgery. In 2009. He and his team established the first one-stop multidisciplinary combined neuro-oncology clinic (CNO) for management of brain tumour patients in Hong Kong. They also introduced awake cortical mapping and fluorescence guided surgery for the management of gliomas. Danny is the founding organiser of the "Hong Kong - Walk around the World for Brain Tumours" Awareness Program (since 2007).

David is currently an Assistant Professor at The Chinese University of Hong Kong. He obtained his medical degree from The University of Hong Kong in 2010 after completing his overseas elective training at the University of Cambridge Addenbrooke’s Hospital, and St Thomas’ Hospital, King’s College London.

During his Neurosurgery Fellowship training, David was awarded the Best Research Award for two consecutive years from the College of Surgeons of Hong Kong (CSHK) in 2016 and 2017. He completed the training in 2018 with a Distinction in his Higher Surgical Training Research Project and was awarded the Best Original Paper Award in 2019 from CSHK.

David is a Council member of the Hong Kong Neurosurgical Society. He is active in both research and teaching. His research interests are endoscopic surgery and minimally invasive surgical techniques in Neurosurgery, head and spine injury.

Jong-Hee obtained his medical degree and PhD degree in Yonsei University College of Medicine, Korea, in 1991 and 2004 respectively. He received his overseas training in Neurosurgery at Washington University and Cleveland Clinic in 2001-2003 and subsequent Neuro-oncology research in 2010-2011 at The University of Toronto Brain Tumour Research Centre. Jong-Hee has joined Yonsei University College of Medicine as academic neurosurgeon since 2003 and currently a full Professor at Department of Neurosurgery and Director of the Brain Tumour Center of Severance hospital.

Maxwell is a third-year MBChB-GPS (Global Physician-Leadership Stream) student at The Chinese University of Hong Kong (CUHK). He graduated from St. Paul’s Co-educational College as the youngest full scorer in the International Baccalaureate Diploma (IBDP) examination at the age of 16 and opted for entry directly into Year 2 to pursue gap year options in academic research related to clinical neuroscience. He has been actively involved in student medical societies, and his roles include Executive Officer in the Department of Clinical Experience at the Hong Kong Student Association of Neuroscience (HKSAN) and Academic Officer of Morningside Medics. Furthermore, he serves as a Faculty Student Ambassador of the Faculty of Medicine, CUHK.

Currently, Maxwell is one of the core investigators in the Enhancing the Use of Telemedicine among Older People In Asia (EUTOPIA) study under supervision by Professor Vincent Mok, and is conducting research on the applications of telemedicine amongst various elderly patient groups, particularly those with behavioral disorders. Moreover, he also does research in neuro-oncology under supervision by Professor H.K. Ng and is now working on molecular characterization of an adult IDH-wildtype glioblastoma cohort with TERTp mutations, aiming to elucidate molecular mechanisms involved in gliomagenesis.

Professor Duffau obtained his master degree in neurosciences (1992) and medical degree (1995) from University of Paris VI (Pierre and Marie Curie University). He received his neurosurgical training at Pitié-Salpêtrière Hospital in Paris (1995-1999) and PhD in neurosciences from University of Paris VI (2000). He was appointed as Professor of Neurosurgery in 2006 and has become Chairman of the Department of Neurosurgery in the Montpellier University Medical Center in France since 2007. Professor Duffau is the Director of the INSERM U1191 Team "Brain Plasticity, Stem cells and Diffuse Low Grade Gliomas" at the National Institute for Health and Medical Research, Institute of Functional Geonomics. He is an expert in the awake cognitive neurosurgery of slow-growing brain tumors, as low-grade gliomas, a routine which he has developed since more than twenty years. His fundamental approach is centered on the concepts of the brain connectomics and neuroplasticity, breaking with the traditional localizationist view of cerebral processing. For his innovative work in neurosurgery and neurosciences, he was awarded Doctor Honoris Causa six times, and he was the youngest recipient of the prestigious Herbert Olivecrona Award from the Karolinska Institute in Stockholm.

Professor Duffau has written four textbooks and over 420 publications in international journals ranging from neurosurgery to fundamental neurosciences, including cognitive sciences and brain plasticity for a total of more than 31,000 citations and with an h-index of 96. He gave more than 560 invited lectures, and was invited as a visiting professor in more than 50 institutions. He is member of Editorial boards of Brain and Language, Neurosurgery and Neuro-oncology and ad-hoc reviewer for around 100 journals (over 950 reviews) including New England Journal of Medicine, Lancet Oncology, Nature Medicine, Nature Reviews Neuroscience, Nature Reviews Neurology; Annals of Neurology, Brain, Cerebral Cortex, Trends in Cognitive Science and Current Biology. He is member of many societies: the French Academy of Medicine, the French Academy of Surgery, the World Academy of Neurological Surgery, the Young Neurosurgeons Award Committee of the World Federation of Neurosurgical Societies, the Scientific Committee of the European Association for Neuro-oncology, to name but a few.

Professor Enam is a US Board certified Neurosurgeon (2002) and currently the Chairman of Department of Surgery, Aga Kan University Hospital, Pakistan and Programme Director in Neurosurgical Training of Aga Khan University. He received his Surgical Fellowship from Ireland (2000) and Canada (2002). Professor Enam received a number of awards and honours for his work and contribution in USA and Pakistan, including Sitara-e-Imtiaz, one of highest honour and civilian award in Pakistan, Excellance Award in Neurosurgery from Pakistan Society of Neurosurgeons and Outstanding Resident Award from Henry Ford Hospital in USA. His areas of research interests are role of extracellular matrix in tumour invasion, immunotherapy for brain tumours and spinal cord regeneration.

Dr Fu received his Bachelor of Science degree of Virology from Wuhan University in 1982. He was the first class of the CUSBEA (China-United States Biochemistry Examination and Application) for graduate training. He obtained his Ph.D. degree from Case Western Reserve University in 1988 and competed postdoctoral training at Harvard in 1988. In 1992, he joined the faculty at University of California, San Diego and rose through the rank. He became a Distinguished Professor of Cellular and Molecular Medicine in 2018 at UC, San Diego.

Throughout his academic career, Dr Fu made fours sets of discoveries: (1) He used partially purified spliceosome to raise a large panel of monoclonal antibodies, which led to the discovery of the first non-snRNP splicing factor SC35, a founding of the SR family of splicing regulators, and demonstrated the function of SR proteins in committing pre-mRNA to the splicing pathway. (2) Dr Fu was also responsible for discovering the SRPK family of splicing kinases highly specific for SR proteins and elucidates a dedicated signaling pathway via these kinases to transduce growth factor signaling to the nucleus to regulate alternative splicing. (3) He pioneered studies on cell fate switches mediated by regulatory RNAs and RNA binding proteins and elucidated an RNA program necessary and sufficient to trans-differentiate fibroblasts into functional neurons. (4) Using this new strategy, he directly converted astrocyte into dopaminergic neurons in brain and demonstrated on a Parkinson’s disease mouse model that such strategy is able to reverse the disease phenotype, suggesting a new strategy to treat neurodegenerative diseases.

Dr. Fu’s contributions to biomedical research have been honored by selection as Searle Scholar (1994), Leukemia and Lymphoma Society Scholar (1997), election to AAAS Fellow (2010). and the Ray Wu Society Award (2016).

Atsushi was graduated from Faculty of Medicine, University of Niigata, Japan in 2008. He did his residency in Neurosurgery in Tokyo Metropolitan Police Hospital (2010-2013) and Tokyo Women’s Medical University (TWMU, 2013-2015). He obtained his PhD degree from Faculty of Advanced Techno-Surgery, Institute of Advanced Biomedical Engineering and Science, TWMU. Atsushi has been appointed as Associate Professor since 2019. His research interests are neurosurgical monitoring (in the areas of intraoperative MRI, awake surgery, MSP and SEP), plasticity and neuromodulation.

Kyi is Clinical Professor at Department of Neurosurgery, North Okkalapa General Hospital, Yangon, Myanmar. He obtained his medical degree in 1994 and Master degree in Medical Science in 1999. He completed his speciality training in Neurosurgery in Yangon General Hospital in 2007.

Kyi has been instrumental in motivating local resources and overseas collaboration in establishing facilities that allow effective neurosurgical investigations and treatments be carried out. This includes the operating room where secure positioning of anaesthetised patients can safely be operated upon, imaging such as CT and MRI, and finally ICU facilities. That allows more complex neurosurgical patients to recover from prolonged anaesthesia and management of traumatic brain injury and brain haemorrhage.

Roger completed his medical degree (MBBS) and higher research degree (MD) at The University of Hong Kong and did his basic and advanced Psychiatry training at National University of Singapore. He is a member of the Royal College of Psychiatrists (UK) and a fellow of the Royal College of Physicians (Canada) and Academy of Medicine (Singapore).

He currently works as Associate Professor and Consultant Psychiatrist at the Department of Psychological Medicine, National University of Singapore (NUS). He is the Education Director coordinating teaching, resident training and research for undergraduate and postgraduate students. His recent research studies the effects of antidepressants on the immune system in animals, as well as the application of technology in clinical services and research, including mobile/electronic health and functional near infrared spectroscopy (fNIRS). He is the author or co-author of more than 130 articles published in peer reviewed journals and 6 books published by prestigious publishers including Hodder Arnold (UK) and Taylor and Francis (US).

Roger is extensively involved in medical education. He disseminated psychiatric knowledge through publications of academic books with global influence. The most recent example is the co-authorship and publication of one of the most commonly used postgraduate textbooks by psychiatric trainees, Revision Notes in Psychiatry (3rd edition), since 1998. He has consistently received several teaching awards such as the NUHS Teaching Excellence Award in 2017 and the Annual Outstanding Tutor Award (2011 – 2016).

Jacque obtained his Bachelor of Science in Biochemistry from the University of Sydney with first class honours and university medal, and then received his PhD in Biochemistry at The Hong Kong University of Science and Technology. Jacque received further post-doctoral training at the Picower Institute for Learning and Memory, Massachusetts Institute of Technology (MIT). During his postgraduate study and postdoctoral training, he received a number of awards including the Croucher Studentship, the Sir Edward Youde Memorial fellowship, the International Brain Research Organization (IBRO) Rita Levi-Montalcini Research fellowship, and Human Frontier Science Program (HFSP) Long-Term fellowship. Recently, He has received the Aspirational Neuroscience Prize, RGC early career award, and NARSAD Young Investigator Award. Jacque has devoted his research to investigate the mechanisms of synaptic plasticity, and will continue to expand his research focus on how such mechanistic defects result in autism-related disorders through the use of multidisciplinary approaches. His long-term goal is to apply multidisciplinary cutting-edge neurotechnology to probe brain function in health and disease.

Professor Ip is currently the Vice-President for Research and Development and the Director of the State Key Laboratory of Molecular Neuroscience at The Hong Kong University of Science and Technology (HKUST). She received her PhD degree in Pharmacology from Harvard Medical School, after which she held the position of Senior Staff Scientist at Regeneron Pharmaceuticals Inc. in New York. Since joining HKUST in 1993, she has served as the Dean of Science, Director of the Biotechnology Research Institute, and Head of the Department of Biochemistry.

Professor Ip is a world-renowned neuroscientist. Her major research interests are in neuronal functions and plasticity, as well as drug discovery for neurodegenerative diseases such as Alzheimer’s disease. She is well-known for her seminal discoveries in the biology of neurotrophic factors, which are proteins that promote the survival, development, and maintenance of neurons in the nervous system. She has also made important contributions towards understanding the molecular mechanisms underlying brain development and synaptic plasticity, and their dysregulation in neurological disorders.

As a highly accomplished researcher, Professor Ip has published 311 papers with over 25,422 SCI citations, and holds 58 patents. She has been elected to the Chinese Academy of Sciences, the World Academy of Sciences, the US National Academy of Sciences, the American Academy of Arts and Sciences, the Hong Kong Academy of Sciences, and the Chinese Academy of Medical Sciences. She currently serves on the editorial boards of PNAS, J Cell Biology, Trends in Neuroscience, National Science Review, and was the Senior Editor of the Journal of Neuroscience.

In recognition of her excellence in science, she has received numerous awards and honours including the National Natural Science Awards, the L’OREAL-UNESCO for Women in Science Award and the 10 Science Stars of China by Nature. Professor Ip is frequently invited to serve with prominent international organizations to steer research directions and policy on a global level. She currently serves as a member of the Leadership Group of the Davos Alzheimer’s Collaborative and the Organizing Committee of the International Common Disease Alliance.

Chae-Yong obtained his Bachelor (1994), Master (1999) and Doctoral (2004) degrees from Seoul National University College of Medicine. After resident training in Neurosurgery (1995-1999) he was recruited to the Armed Forces Capital Hospital as Military Neurosurgeon (2000-2002). He joined Seoul National University (SNU) Bundang Hospital as academic neurosurgeon in 2004 and has become a Professor since 2016. He is also holding a Professorship at Department of Neurosurgery, Seoul National University (SNU) College of Medicine. Chae-Young is currently the Chief of Neuro-oncology Division of Department of Surgery of SNU Bundang Comprehensive Cancer Hospital and Bundang Clinical Neuro-Science Institute.

Chae-Yong is specialised in brain tumour surgery and neuro-oncology, in particular malignant gliomas. Quality of life of this group of patients is his research interest. Chae-Yong introduced the multidisciplinary approach to the clinic for the management of brain tumours in Korea.

Owen holds a Bachelor of Medical Sciences and Medical degree from The Chinese University of Hong Kong. He pursued his PhD in Neuroscience under the supervision of Professor Thomas Mrsic-Flogel at University College London in the UK and won the runner-up award of the 2014 Eppendorf & Science Prize for Neurobiology based on his PhD works.

Owen serves as a principal investigator at the Gerald Choa Neuroscience Center and the Li Ka Shing Institute of Health Sciences of the Chinese University of Hong Kong. Leading a team with expertise in biology, chemistry and engineering, his research works focus on (i) the principles by which neural circuits mediate sensory perception and behavior, (ii) neurovascular and glial dysfunction in neurodegeneration, and (iii) the development of novel neuroimaging tools.

Hei-Ming is a psychiatrist-neuroscientist in training and is a clinical lecturer in the Department of Psychiatry, The Chinese University of Hong Kong. He has been involved in the development of neuroscientific research tools for six years, with his foundational work published in leading journals as first and corresponding authors. His work has been awarded a Gold Medal in the 46th International Exhibitions of Inventions Geneva and Honourable Mention in Nikon Small World Photomicrography Competition. Although a young researcher, Hei-Ming has already secured millions of dollars for further basic and translational development on his inventions. His current research interests include neuroscientific research tool development, biomarker discovery, neuropsychopharmacology, and neural mechanisms of psychiatric diseases.

Joseph received his medical degree in 1989 from The Chinese University of Hong Kong (CUHK)/ Prince of Wales Hospital (PWH) where he completed his residency training in Neurosurgery. He did his clinical fellowship in the Department of Neurosurgery, University of Cambridge/ Addenbrooke’s Hospital Cambridge in 1995-1996.

Joseph was board-certified as specialist neurosurgeon in 1997 and had been appointed as Consultant Neurosurgeon (1998-2005) and Honorary Associate Professor (since 1998) at the Division of Neurosurgery, Department of Surgery, PWH/ CUHK. He then started his private practice in 2015. His main areas of clinical interests are spine surgery and subarachnoid haemorrhage. Joseph is an enthusiast in providing surgical training in spine for both neuro- and orthopaedic surgeons. He has been a Council Member of the Hong Kong Stroke Society since 2001.

Liam is a 5th year medical student from The University of Edinburgh with a strong interest in neurology. As the President of Edinburgh University Neurological Society, he oversees the projects within five domains, namely International Conference, Neuroanatomy, Neuroscience, Neurosurgery, and Public Engagement. He looks forward to integrating online platforms to their projects.

Some widely accoladed projects include Neurotheatre, a theatrical lecture in which audience follows a patient from injury to recovery, witnessing a 'live' performance of brain surgery; and TED-like monthly talks, where experts are invited to share their views on highly debated neuroscience topics such as neurodegeneration and regeneration, mental health, artificial intelligence etc.

Michael is a Consultant Neurosurgeon at Pamela Youde Nethersole Eastern Hospital in Hong Kong. Serving as the President of the Hong Kong Neurosurgical Society, he is actively involved in the development of neurosurgery and training of young neurosurgeons in Hong Kong. He is an Honorary Clinical Associate Professor at Department of Surgery, The Chinese University of Hong Kong.

Michael is devoted in promoting neuroscience knowledge in Hong Kong. As the Vice-President of the Hong Kong Brain Foundation, a charitable organisation aimed at promoting brain health and supporting brain related research projects and public education programmes, he goes the extra mile to introduce to the younger generation in the capacity of the coordinator of the Hong Kong Brain Bee Competition the realm of neuroscience. Besides, he is the webmaster and councillor of the Hong Kong Movement Disorder Society and Hong Kong Neuro-Oncology Society. Moreover, he is a trainer and the training centre coordinator of the Advanced Stroke Life Support (ASLS) course in Hong Kong.

Laura is currently a final year Global Physician-Leadership Stream (GPS) medical student at The Chinese University of Hong Kong. Prior to her medical studies, she graduated from University College London with a Biomedical Sciences degree with honours. She currently chairs as the Director of Clinical Experience within the Hong Kong Student Association of Neuroscience, an association that focuses on broadening awareness of neuroscience within the wider Hong Kong student community.

During her time at UCL, she discovered her passion for the study of Neuroscience and completed her undergraduate thesis within the field of behavioural neuroscience. Since then, she has narrowed her research interest to neuroimaging and its applications in Neurosurgery. She has completed multiple research projects at the University of Toronto, Harvard Medical School, and the Brigham and Women’s Hospital, published numerous papers and presented at a number of international conferences. Currently, she also serves as an active member of the local research community, focusing on the use of MRI-associated imaging modalities to improve clinical outcomes of Deep Brain Stimulation patients.

Vincent's research aims to understand mechanisms of dementia and to investigate strategies that may help to prevent dementia and cerebrovascular disease. He is the first in Asia to report the association of cerebral small vessel disease and cognitive impairment, as well as the first in the world to utilize in-vivo amyloid PET imaging in understanding the contribution of amyloid pathology in poststroke dementia. Moreover, he also specializes in Parkinson's disease and was one of the pioneers of developing Deep Brain Stimulation programme in the region.

He received the Higher Education Outstanding Scientific Research Output Award (Science & Technology) in Natural Sciences (1st Class), from the Ministry of Education, People's Republic of China in 2011 for his research in cerebrovascular disease, and the Excellent Research Award, from the Food and Health Bureau of the Hong Kong Special Administrative Region in 2017 for his research in vascular cognitive disorder. He received 7 times Teacher of the Year Award and the Master Teacher Award.

Vincent has authored more than 300 publications in peer-reviewed international journals (with book chapters), with publications at Lancet, JAMA, Lancet Neurology, Nature Reviews Neurology, JAMA Psychiatry, Alzheimer's & Dementia, Annals of Neurology, Neurology, JNNP and Stroke.

Dr Vairavan is an Associate Professor and Consultant Neurosurgeon in University of Malaya (UM). He did his basic medical degree and Master degree in Surgery in the National University of Malaysia (UKM). He started his Neurosurgical training in UM in 2006 and completed his training in Addenbrookes Hospital, Cambridge in 2012. He acquired the Neurosurgical Fellowship from the Intercollegiate Board of Surgery in UK. He spent a further 6 months in 2012 doing an Honorary Fellowship in Epilepsy in University College London. He was recognised as a Malaysian National Specialist Registry (NSR) gazetted consultant Neurosurgeon in 2013.

His clinical interest lies in Neuro Oncology, Epilepsy and Skull Base Surgery. He works closely with the adult and paediatric Neurologists in UM and has built up a successful Epilepsy surgery Unit which screens an average of 50 patients a year, of whom about 20 undergo surgery. With his fellow neurosurgeons and neuro-oncologists, he also runs a dedicated Neuro-oncology Unit which provides the highest standards of care for brain tumour patients.

His research interests include genetic polymorphisms and mutations in primary and secondary brain tumours, traumatic brain injury and its sequeala, innovations in surgery and training. He is also actively involved in academic teaching and supervision of both undergraduate and post graduate Masters and PhD students.

H.K. is Chair Professor at CUHK. His interests are in the molecular pathology of brain tumours, both adult and paediatric. H.K. is both a neuropathologist and general pathologist. He is an Associate Editor of Laboratory Investigation and an Associate Editor of Neuro-Oncology Advances, and is also on the Editorial Boards of Acta Neuropathologica, Brain Pathology, Neuropathology and Applied Neurobiology, Clinical Neuropathology, Pathology and International Journal of Clinical and Experimental Pathology. He was a member of the Consensus Group of the 2007 and 2016 WHO classifications of the brain tumours. And for the upcoming WHO 2020, he is one of the only 10 neuropathologists from around the world selected to make up the Consensus Group.

H.K. was part of the team who received The 2nd Tier Prize of The National Science and Technology Award of China in 2010 and the First Tier Prize of the Science and Technology Award of Shanghai in 2019. He received The International Academy of Pathology Gold Medal twice in 2006 and 2017.

Wai is a Glasgow medical graduate of 1978 and trained in Neurosurgery at Glasgow’s Institute of Neurological Sciences [1983-1986]. He did his research fellowship at Department of Neurosurgery, Massachusetts General Hospital/ Harvard Medical School in 1990-1991. He has joined The Chinese University of Hong Kong (CUHK)/ Prince of Wales Hospital (PWH) as a faculty member in academic neurosurgery since 1986 and became Chief in Neurosurgery [1988-2019] and Chair Professor in 2003. He is currently Emeritus Professor and Clinical Professional Consultant, and Director of the CUHK Otto Wong Brain Tumour Centre.

Wai has a strong interest in clinical and experimental head injury, and more recently cell therapy, cell biology in brain tumours and axonal injury in central nervous system. He has the expertise and motivation to do prospective clinical studies as Principle Investigator in brain injuries. He is author of 450 peer-reviewed publications.

Wai is an active participant of college and society activities locally and internationally. He has been doing medico-legal work since 1992. He is active in undergraduate and postgraduate surgical education, and specialist training in Neurosurgery, as Vice President [Internal Affairs] of The College of Surgeons of Hong Kong (CSHK), Chief Examiner for Neurosurgery and Past Chairman of the Neurosurgery Board [2007-2019] of the CSHK.

Stephen graduated in medicine from Bart’s Medical College in 1994 and did his basic surgical training in the East Midlands. He trained in neurosurgery in Nottingham and Romford before starting the Cambridge training scheme. Stephen was made Clinical Lecturer in 2005 and was appointed Consultant Neurosurgeon with a special interest in managing brain tumours in 2008. He is currently the Network Lead for brain tumours at the Anglian Cancer Network and is Co-Director of the Neuro-Oncology Programme at the Cambridge Cancer Centre. Stephen introduced 5-ALA fluorescence guided surgery to Cambridge to help maximise tumour removal and, with colleagues, regularly teach other surgeons how to use these methods. His practice is largely based around the surgical management of malignant brain tumours (gliomas and metastases).

In 2010 he was awarded a NIHR Clinician Scientist Fellowship. His research interest involves using advanced imaging methods to study the effects of tumours on the normal brain surrounding brain tumours. This work aims to better outline the invasive margin of these tumours and understand the effect of these tumours and treatment on the functioning of the normal brain. In 2016 he developed the Cambridge Brain Tumour Imaging Laboratory - UK's first dedicated brain tumour imaging analysis laboratory. He has been a member of the National Cancer Research Institute (NCRI) Brain Tumour Study Group and the Neuro-oncology Clinical Study Group and was the chair the Imaging and Technology Sub- Group. He is a Bye-Fellow of Queens' College and is the Director of Studies of Clinical Medicine.

Sith is Associate Professor of Department of Medicine (Neurology) and Assistant Dean for International Relations of the Faculty of Medicine Siriraj Hospital, Mahidol University in Bangkok, Thailand. He also serves as Manager of Siriraj Center of Research Excellence Management (CORE-M) Unit.

Sith received his medical degree from the Faculty of Medicine at Siriraj Hospital, Mahidol University. He completed research training in Neuro-immunology at Mayo Clinic College of Medicine in Rochester, Minnesota, and then neurology residency and neuro-oncology fellowship at Duke University Medical Center in Durham, North Carolina, USA. His clinical expertise includes treatment of patients with brain tumors and neurologic complications of cancer. His research has focused on preclinical and clinical development of novel therapeutic strategies including drug delivery system and precision medicine for brain tumors.

As an active contributor to medical literature, Sith has published more than 80 full-length manuscripts, invited reviews, and international book chapters. In addition, he is also a reviewer for several international journals and granting agencies.

Djaina is currently a Clinical Linguist and Assistant Professor in the Department of Neurosurgery, Erasmus MC University Medical Center in Rotterdam, The Netherlands. She is a linguistics graduate of Utrecht University and a PhD of Erasmus MC University. In 2014-2016, Djaina worked as a coordinator for the Groningen Centre of Expertise for Language and Communication Disorders, a well-known and trusted centre for the development of language tests and their application. Djaina’s expertise concerns language monitoring before, during and after awake brain tumour surgery. Her own primary research interests are in neurolinguistics and cognitive research in patient with acquired brain lesions, in particular gliomas.

Venus is a Clinical Psychologist specialising in neuropsychology and adult psychology. She graduated from the University of Hong Kong (HKU) and thereafter received her Master Degree in Clinical Psychology and Doctor of Philosophy in the Faculty of Medicine from The Chinese University of Hong Kong (CUHK). She was a visiting scholar in the Department of Neurology, David Geffen School of Medicine in the University of California, Los Angeles (UCLA). She is experienced in psychological intervention and mind-body therapy for adult individuals with psychological disorders. Her research interest has been on clinical neuropsychology and her studies have been published in top-ranking journals, e.g. Neurology. She serves as Adjunct Assistant Professor in HKU and CUHK. She is an Associate Fellow of the Hong Kong Psychological Society, the Division of Clinical Psychology and an Associate Member of the American Psychological Association.

Chottiwat qualified as a specialist neurosurgeon in 1995 and is currently Assistant Professor in Department of Neurological Surgery, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok. He has completed overseas training in Tokyo (1999), Pittsburgh (2003) and Montpellier (2004). He received the Higher Graduate Diploma in Surgical Science from Mahidol University in 2005. His clinical interests are around pituitary and hypothalamus, and glioma surgery.

Professor UNSGÅRD has been a Professor at NTNU for 30 years, where he also was Dean of the Medical Faculty for 6 years. He was Chief of Neurosurgical Dept and Head of Neuro-division, St Olav University Hospital for 22 years. He has been using navigated 3D Ultrasound in neurosurgical operations for 23 years. He has published 195 scientific articles in peer reviewed journals and 8 book chapters. The research encompasses cell biology, MR technology and in the last 20 years mostly the use of ultrasound technology to guide and improve neurosurgical operations. He has been entrusted different national and international professional positions. As a politician he was a member of the City Council of Trondheim for 7 years. He left politics about two decades ago when he moved out of the city to a farm nearby with his wife and five children. Here they have a lot of space for their two horses and for receiving visits from family including their 6 grandchildren. In 2009 Professor UNSGÅRD was knighted by the King of Norway (“Knight of St Olavs Order”) for his scientific and professional achievements.

Kuo-chen is a 1985 medical graduate of the Taiwan Chung-Shan Medical College. He did his residency training in neurosurgery in the prestigious Chang Gung Memorial Hospital in Linkuo. He subsequently gets interested in molecular biology of brain tumours and did his research fellowship in Brain Tumour Research Centre of University of California, San Francisco (UCSF) in 1999-2001. He has conducted structured research in biomarkers for glioma. He is currently Professor of Neurosurgery at Chang Gung Memorial Hospital Linkuo Medical Center, continues to work on awake craniotomy, intraoperative brain mapping, focused ultrasound and nanomedicine.

Queenie is a 4th year medical student and a candidate for Master of Science in Research Medicine at The Chinese University of Hong Kong. She serves as the Founding President of the Hong Kong Student Association of Neuroscience (HKSAN) which aims to connect and inspire Hong Kong students for the advancement and popularisation of neuroscience. She has been engaged in various local and overseas neuroscience research projects and is now actively involved in neuro-oncology studies, especially in characterising the molecular and clinical profiles of brain tumours.

In HKSAN, she oversees three departments focusing on scientific research, clinical experience, and public health respectively. With the concerted efforts of all Founding Committee members, they have organised their 1st Annual Conference, numerous research and career webinars, and public advocacy events, which cover a wide range of areas including but not limited to neurology, neurosurgery, neuropathology, psychiatry, basic neuroscience, and computational neuroscience.

Peter is a 2004 medical graduate of The University of Hong Kong where he has obtained a Master degree in Medical Science (2010). He received the First Prize of Research of the Year Award from The College of Surgeons of Hong Kong and the First Prize of Higher Surgical Trainee Paper Presentation from the Hong Kong Neurosurgery Society during his Neurosurgical Training. He was qualified as Specialist Neurosurgeon in 2013. He subsequently matures in different areas: (1) neuro-oncology, (2) an elected member of the Specialty Board in Neurosurgery, a voice for the young neurosurgeons, and (3) prolific writer in brain tumours and emergency neurosurgery.

Tseng-Tsai is a 1985 medical graduate of the National University of Singapore. He completed his neurosurgical training in Melbourne (FRACS 1994), and functional neurosurgery fellowship in Toronto, Seattle and Grenoble. Having worked in the National Neurological Institute in Singapore, the private sector and now Clinical Associate Professor and Senior Consultant Neurosurgeon and Head of Division of neurosurgery of National University Hospital in Singapore, Tseng-Tsai is in a great position to excel in areas of functional neurosurgery, brain tumour, trauma and virtual reality. The Low-grade Glioma Conjoint Meeting of this year, Tseng-Tsai is the primary driving force behind us.

Dr Zhu was graduated from the medical school of Jinan University in 1984, He obtained the degree of Master of Philosophy from The Chinese University of Hong Kong in 1992. He received functional and paediatric neurosurgery training in Toronto in 1998. He acquired the qualification of FCSHK, FRCS(Edin) and FHKAM(Surg) in 1998. Currently he is the Consultant Neurosurgeon (part-time) and Honorary Clinical Associate Professor in the Department of Surgery, Prince of Wales Hospital/ The Chinese University of Hong Kong. His main fields of clinical and research interests are functional neurosurgery, paediatric neurosurgery and neurorehabilitation. He is also a member of the World Society for Stereotactic and Functional Neurosurgery (WSSFN), International Society of Pediatric Neurosurgery (ISPN) and Hong Kong Neurosurgical Society, council member of Hong Kong Movement Disorder Society and Hong Kong Epilepsy Society.